Tocopherol-mediated modulation of age-related changes in microglial cells: Turnover of extracellular oxidized protein material

Free Radical Biology and Medicine

Volumn 40, Issue 12, 2006, Pages 2126-2135

  Stolzing, Alexandra ^a   Widmer, Rebecca ^b   Jung, Tobias ^b   Voss, Peter ^b   Grune, Tilman ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Aging; CD36; Microglia; Oxidized proteins; Protein degradation; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CD36 ANTIGEN; PROTEIN; TOCOPHEROL;

AGING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL METABOLISM; CELL VACUOLE; CONTROLLED STUDY; MICROGLIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; TURNOVER TIME;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD36; APOPTOSIS; LYSOSOMES; MICROGLIA; MYELIN BASIC PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; RATS, WISTAR; TOCOPHEROLS;

ANIMALIA;

EID: 33745139199     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.02.011     Document Type: Article

References (56)

1. Butterfield D.A., and Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech. Ageing Dev. 122 (2001) 945-962
2. Beal M.F. Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 32 (2002) 797-803
3. Ramasamy R., Vannucci S.J., Yan S.S., Herold K., Yan S.F., and Schmidt A.M. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15 (2005) 16R-28R
4. Dickson D.W. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56 (1997) 321-339
5. Muelhauser F., Liebl U., Kuehl S., Walter S., Bertsch T., and Fassbender K. Aggregation dependet interaction of the Alzheimers beta-amyloid and microglia. Clin. Chem. Lab. Med. 39 (2001) 313-316
6. Smith M.E. Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE. Microsc. Res. Tech. 54 (2001) 81-94
7. Stolzing A., and Grune T. Impairment of protein homeostasis and decline of proteasome activity in microglial cells from adult Wistar rats. J. Neurosci. Res. 71 (2003) 264-271
8. Dipatre P.L., and Gelmann B.B. Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus. J. Neuropathol. Exp. Neurol. 56 (1997) 143-149
9. Heppner F.L., Roth K., Nitsch R., and Hailer N.P. Vitamin E induces ramification and down regulation in cultured microglial cells. Glia 22 (2001) 180-188
10. Grundmann M., Grundman M., and Delaney P. Antioxidant strategies for Alzheimer's disease. Proc. Nutr. Soc. 61 (2002) 191-202
11. Guilian D., Baker T.J., Shih L.-C.N., and Lachmann L. Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Neurosci. 164 (1986) 594-604
12. Grune T., Reinheckel T., Joshi M., and Davies K.J.A. Protein degradation in cultured liver epithelial cells during oxidative stress. J. Biol. Chem. 270 (1995) 2344-2351
13. Eylar E.H., Westall F.C., and Brostoff S. Allergic encephalomyelitis. An encephalitogenic peptide derived from the basic protein of myelin. J. Biol. Chem. 246 (1971) 3418-3424
14. Stolzing A., and Grune T. Neuronal apoptotic bodies: phagocytosis and degradation by primary microglial cells. FASEB J. (2004) (express 10.1096:fj.03-0374fje)
15. Leist M., Raab B., Maurer S., Rosick U., and Brigelius-Flohe R. Conventional cell culture media do not adequately supply cells with antioxidants and thus facilitate peroxide-induced genotoxicity. Free Radic. Biol. Med. 21 (1996) 297-306
16. Stolzing A., Wengner A., and Grune T. Degradation of oxidized extracellular proteins by microglia. Arch. Biochem. Biophys. 400 (2002) 171-179
17. Kalla R., Bohatschek M., Kloss C.U., Krol J., von Maltzan X., and Raivich G. Loss of microglial ramification in microglia-astrocyte cocultures: involvement of adenylate cyclase, calcium, phosphatase, and Gi-protein systems. Glia 41 (2003) 50-63
18. Guilian D., Vaca K., and Corpuz M. Brain glia release factors with opposing actions upon neuronal survival. J. Neurosci. 13 (1993) 29-37
19. Hanisch U.K. Effects of interleukin-2 and interferons on the nervous system. In: Ader R., Felten D.L., and Cohen N. (Eds). Psychoneuroimmunology (2001), Academic Press, San Diego 585-631
20. Sloane J.A., Hollander W., Moss M.B., Rosene D.L., and Abraham C.R. Increased microglial activation and nitration in white matter of the aging monkey. Neurobiol. Aging 20 (1999) 395-405
21. Streit W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40 (2002) 133-139
22. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., DeClercq E., Vescovi A., Bagetta G., Kollias G., Meldolesi J., and Volterra A. CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4 (2001) 702-710
23. Campbell I.L. Transgenic mice and cytokine actions in the brain: bridging the gap between structural and functional neuropathology. Brain Res. Rev. 26 (1998) 327-336
24. Hanisch U.K. Microglia as a source and target of cytokines. Glia 40 (2002) 140-155
25. Raivich G., Bluethmann H., and Kreutzberg G.W. Signaling molecules and neuroglial activation in the injured central nervous system. Keio J. Med. 45 (1996) 239-247
26. Ye S.M., and Johnson R.W. Increased interleukin-6 expression by microglia from brain of aged mice. J. Neuroimmunol. 93 (1999) 139-148
27. Muench G., Gasic-Milenkovic J., and Arendt T. Effect of advanced glycation endproducts on cell cycle and their relevance for Alzheimer's disease. J. Neural. Transm. 65 (2003) 63-71
28. Aschner M., Allen J.W., Kimelberg H.K., LoPachin R.M., and Streit W.J. Glial cells in neurotoxicity development. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 151-173
29. Banati R.B., Gehrmann J., Schubert P., and Kreutzberg G.W. Cytotoxicity of microglia. Glia 7 (1993) 111-118
30. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
31. Vatassery G.T. Vitamin E. Neurochemistry and implications for neurodegeneration in Parkinson's disease. Ann. N. Y. Acad. Sci. 669 (1992) 97-109
32. Azzi A., Ricciarelli R., and Zingg J.M. Non-antioxidant molecular functions of α-tocopherol (vitamin E). FEBS Lett. 519 (2002) 8-10
33. Cachia O., Benna J.E., Pedruzzi E., Descomps B., Gougerot-Pocidalo M.A., and Leger C.L. Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation. J. Biol. Chem. 273 (1998) 32801-32805
34. Egger T., Schuligoi R., Wintersperger A., Amann R., Malle E., and Sattler W. Vitamin E (alpha-tocopherol) attenuates cyclo-oxygenase 2 transcription and synthesis in immortalized murine BV-2 microglia. Biochem. J. 370 (2003) 459-467
35. Pitchumoni S.S., and Doraiswamy P.M. Current status of antioxidant therapy for Alzheimer's disease. J. Am. Geriatr. Soc. 46 (1998) 1566-1572
36. Tasinato A., Boscoboinik D., Bartoli G.M., Maroni P., and Azzi A. d-Alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 12190-12194
37. Bulteau A.L., Szweda L.I., and Friguet B. Age-dependent declines in proteasome activity in the heart. Arch. Biochem. Biophys. 397 (2002) 298-304
38. Chondrogianni N., Stratford F.L., Trougakos I.P., Friguet B., Rivett A.J., and Gonos E.S. Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation. J. Biol. Chem. 278 (2003) 28026-28037
39. Keller J.N., Huang F.F., and Markesbery W.R. Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience 98 (2000) 149-156
40. Sitte N., Huber M., Grune T., Ladhoff A., Doecke W.D., von Zglinicki T., and Davies K.J.A. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J. 14 (2000) 1490-1498
41. Sitte N., Merker K., von Zglinicki T., Davies K.J.A., and Grune T. Protein oxidation and degradation during cellular senescence of human BJ fibroblast: Part II. Aging of non-dividing cells. FASEB J. 14 (2000) 2503-2510
42. Sitte N., Merker K., von Zglinicki T., Grune T., and Davies K.J.A. Protein oxidation and degradation during cellular senescence of human BJ fibroblasts: Part I. Effects of proliferative senescence. FASEB J. 14 (2000) 2495-2502
43. Stadtman E.R., Starke-Reed P.E., Oliver C.N., Carney J.M., and Floyd R.A. Protein modification in aging. Exs. 62 (1992) 64-72
44. Cuervo A.M., and Dice J.F. Age-related decline in chaperone-mediated autophagy. J. Biol. Chem. 275 (2000) 31505-31513
45. Ivy G.O., Schottler F., Wenzel J., Baudry M., and Lynch G. Inhibitors of lysosomal enzymes: accumulation of lipofuscin-like dense bodies in the brain. Science 226 (1984) 985-987
46. Olea M.T., Ma H., and Nagata T. Quantitative assessment of lysosomal size, number and enzyme activity in mouse kidney during maturational development. Cell Mol. Biol. 37 (1991) 679-685
47. Park S.C. Functional recovery of senescent cells through restoration of receptor-mediated endocytosis. Mech. Ageing Dev. 123 (2002) 917-926
48. Vetvicka V., Fornusek L., and Zidkova J. The expression of Fc and complement receptors in young, adult and aged mice. Immunology 56 (1985) 73-80
49. Mitrasinovic O.M., Vincent V.A., Simsek D., and Murphy Jr. G.M. Macrophage colony stimulating factor promotes phagocytosis by murine microglia. Neurosci. Lett. 344 (2003) 185-188
50. Takeda H., Tomita M., Tanahashi N., Kobari M., Yokoyama M., Takao M., Ito D., and Fukuuchi Y. Hydrogen peroxide enhances phagocytic activity of ameboid microglia. Neurosci. Lett. 240 (1998) 5-8
51. Gurley R., and Dice J.F. Degradation of endocytosed proteins is unaltered in senescent human fibroblasts. Cell Biol. Int. Rep. 12 (1998) 885-894
52. Devaraj S., Hugou I., and Jialal I. Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages. J. Lipid Res. 42 (2001) 521-527
53. Febbraio M., Hajjar D.P., and Silverstein R.L. CD36: a class B scavenger receptor involved in angiogenesis, atheriosclerosis, inflammationm and lipid metabolism. J. Clin. Invest. 108 (2001) 785-791
54. Dini L., Rossi L., Marchese E., Ruzittu M.T., and Rotilio G. Age-related changes in the binding and uptake of Cu, Zn superoxide dismutase in rat liver cells. Mech. Ageing Dev. 90 (1996) 21-33
55. Malorni W., Testa U., Rainaldi G., Tritarelli E., and Peschle C. Oxidative stress leads to a rapid alteration of transferrin receptor intravesicular trafficking. Exp. Cell Res. 241 (1998) 102-116
56. Azzi A., and Stocker A. Vitamin E: non-antioxidant roles. Prog. Lipid Res. 39 (2000) 231-255